m+Medelevator.RU
← Поиск публикаций
Advances in neonatal care : official journal of the National Association of Neonatal Nurses · 2025

Digestive Fluid Reinfusion via Nasojejunal Tube Improved Dyspepsia After a Primary Anastomosis in Intestinal Atresia.

СтатьяКлинический случайНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Zuo Maoyi, Xia Shiwen, Liu Jing, Dai Lilu, Han Yue, Ji Zhangyan, Zhu Huaping

Аннотация

BACKGROUND: Surgery is necessary to treat congenital intestinal atresia (IA). Infants may be prone to gastrointestinal function disorder after intestinal resection. Dyspepsia is a common complication after bowel resection in neonates, and achieving rapid recovery of digestive function postoperatively remains a significant clinical challenge.

PURPOSE: This article describes the detailed methodology for digestive fluids reinfusion (DFR) and explores its impact on gastrointestinal function recovery. We aimed to develop DFR for managing postoperative digestive dysfunction in neonates following primary anastomosis for IA.

METHODS: This case presents a 2340-g, 35-week, and 2-day gestation female infant with gastrointestinal dysfunction after surgery for IA. The premature infant received DFR via nasojejunal tube to observe digestive function recovery.

RESULTS: After 7 days of continuous reinfusion, the infant's gastrointestinal function improved significantly. Milk intake increased from 50 ml/kg/d to 180 ml/kg/d, and stools transitioned from milky to a yellow mushy consistency.

IMPLICATIONS FOR PRACTICE: Dyspepsia is a common complication after bowel resection in neonates. Achieving rapid recovery of digestive function postoperatively remains a significant clinical challenge. The reinfusion of digestive fluids via nasojejunal tube is expected to provide a promising treatment option for neonatal patients in the future.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты